2-73385903-TGGAGGAGGAGGAGGAGGAGGAGGAGGA-TGGAGGAGGAGGAGGAGGAGGAGGAGGAGGAGGAGGAGGAGGAGGAGGAGGA
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP3BP6
The NM_001378454.1(ALMS1):c.51_74dupGGAGGAGGAGGAGGAGGAGGAGGA(p.Glu18_Glu25dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. It is difficult to determine the true allele frequency of this variant because it is of type INS_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. E25E) has been classified as Likely benign.
Frequency
Consequence
NM_001378454.1 disruptive_inframe_insertion
Scores
Clinical Significance
Conservation
Publications
- Alstrom syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia, G2P, Orphanet, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ALMS1 | NM_001378454.1 | c.51_74dupGGAGGAGGAGGAGGAGGAGGAGGA | p.Glu18_Glu25dup | disruptive_inframe_insertion | Exon 1 of 23 | ENST00000613296.6 | NP_001365383.1 | |
| ALMS1 | NM_015120.4 | c.51_74dupGGAGGAGGAGGAGGAGGAGGAGGA | p.Glu18_Glu25dup | disruptive_inframe_insertion | Exon 1 of 23 | NP_055935.4 | ||
| LOC105374804 | XR_007087045.1 | n.-246_-223dupTCCTCCTCCTCCTCCTCCTCCTCC | upstream_gene_variant | |||||
| LOC105374804 | XR_007087053.1 | n.-246_-223dupTCCTCCTCCTCCTCCTCCTCCTCC | upstream_gene_variant |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000279 AC: 4AN: 143532Hom.: 0 Cov.: 0 show subpopulations
GnomAD4 exome AF: 0.0000574 AC: 32AN: 557738Hom.: 0 Cov.: 0 AF XY: 0.0000369 AC XY: 11AN XY: 297828 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
Age Distribution
GnomAD4 genome AF: 0.0000278 AC: 4AN: 143636Hom.: 0 Cov.: 0 AF XY: 0.0000431 AC XY: 3AN XY: 69662 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
ALMS1-related disorder Uncertain:1
The ALMS1 c.54_74dup21 variant is predicted to result in an in-frame duplication (p.Glu22_Glu28dup). To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Alstrom syndrome Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant has not been reported in the literature in individuals affected with ALMS1-related conditions. This variant is not present in population databases (gnomAD no frequency). This variant, c.54_77dup, results in the insertion of 8 amino acid(s) of the ALMS1 protein (p.Glu22_Glu29dup), but otherwise preserves the integrity of the reading frame. -
not specified Benign:1
Variant summary: The ALMS1 variant, c.54_74dup21 (p.Glu22_Glu28dup) is located in a Glu repetitive region (Glu13_Glu28). The variant was absent in 83366 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. No variants located in this Glu repetitive region were reported in HGMD database and other variants (including deletion and duplication) located in this repetitive region were reported in LOVD database and classified as likely benign/benign. In addition, other duplication variants (p.Glu26_Glu28dup, p.Glu23_Glu24dup, p.Glu24dup) located in this Glu repetitive region have been classified as benign by our laboratory. To our knowledge, no occurrence of c.54_74dup21 in individuals affected with Cardiomyopathy and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely benign. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at